Information Journal Paper
APA:
Copy. (2017). Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants. DIGESTIVE AND LIVER DISEASE, 49(-), 157-162. SID. https://sid.ir/paper/733211/en
Vancouver:
Copy. Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants. DIGESTIVE AND LIVER DISEASE[Internet]. 2017;49(-):157-162. Available from: https://sid.ir/paper/733211/en
IEEE:
Copy, “Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants,” DIGESTIVE AND LIVER DISEASE, vol. 49, no. -, pp. 157–162, 2017, [Online]. Available: https://sid.ir/paper/733211/en